Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Int J Pharm. 2013 Mar 10;445(1-2):134-40. doi: 10.1016/j.ijpharm.2013.02.007. Epub 2013 Feb 10.
The aim of the study was to observe the characteristic of permeation of capsaicin across jejunum, ileum and colon in the rat, and to investigate the role of transient receptor potential cation channel (TRPV1). The interaction of capsaicin with P-glycoprotein (P-gp), multidrug resistance-associated protein 2 (MRP2) and breast cancer resistance protein (BCRP) was also investigated.
The transport of capsaicin across three intestinal segments in rats was investigated using Ussing-chamber System.
The permeability of capsaicin across the colonic ileac or jejunal membrane was significantly different in M-S direction (11.679 ± 2.001, 5.336 ± 1.248, 1.395 ± 0.673, ×10(-6)cm/s). TRPV1 non-competitive antagonist ruthenium red significantly decreased the permeability of capsaicin in M-S direction across colonic membrane. The permeability of capsaicin could also be inhibited unconventionally by the BCRP inhibitor novobiocin in M-S direction across colon. However, either the P-gp inhibitor verapamil or the MRP2 inhibitor probenecid did not affect the transport of capsaicin in all three segments.
We firstly proved that the permeability of capsaicin across colon was significantly higher than that across jejunum or ileum. Furthermore, TRPV1 might mediate the transport of capsaicin across the intestinal membrane. Therefore, the colon-specific highest permeation of capsaicin could be the consequence of the colon-specific distribution of TRPV1. For another, there may be another transport pathway mediating the permeation of capsaicin in M-S direction, which could be inhibited by novobiocin.
观察辣椒素在大鼠空肠、回肠和结肠中的渗透特征,并探讨瞬时受体电位阳离子通道(TRPV1)的作用。还研究了辣椒素与 P 糖蛋白(P-gp)、多药耐药相关蛋白 2(MRP2)和乳腺癌耐药蛋白(BCRP)的相互作用。
采用 Ussing 室系统研究辣椒素在大鼠三个肠段的转运情况。
辣椒素在 M-S 方向穿过回肠或空肠的结肠膜的通透性有显著差异(11.679±2.001、5.336±1.248、1.395±0.673,×10(-6)cm/s)。TRPV1 非竞争性拮抗剂钌红显著降低了辣椒素在 M-S 方向穿过结肠膜的通透性。BCRP 抑制剂新生霉素也能非传统地抑制辣椒素在 M-S 方向穿过结肠的通透性。然而,P-gp 抑制剂维拉帕米或 MRP2 抑制剂丙磺舒均不能影响所有三个肠段中辣椒素的转运。
我们首次证明辣椒素穿过结肠的通透性明显高于穿过空肠或回肠的通透性。此外,TRPV1 可能介导辣椒素穿过肠膜的转运。因此,辣椒素在结肠的特异性高渗透性可能是 TRPV1 在结肠的特异性分布的结果。另一方面,可能存在另一种介导 M-S 方向辣椒素渗透的转运途径,该途径可被新生霉素抑制。